Tandem Diabetes Care (TNDM) Non-Current Debt (2013 - 2018)
Tandem Diabetes Care's (TNDM) quarterly Non-Current Debt came in at $77.1 million in Q2 2018, up 3.24% on a YoY basis from $74.7 million in Q2 2017, and up 0.91% quarter-over-quarter from $76.4 million in Q1 2018.
Analysis
Tandem Diabetes Care (TNDM) Non-Current Debt (2013 - 2018) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Non-Current Debt for 6 consecutive years, with $77.1 million the latest figure, recorded in Q2 2018.
- For the quarter ending Q2 2018, Non-Current Debt rose 3.24% year-over-year to $77.1 million; the trailing twelve-month figure through Jun 2018 stood at $77.1 million (up 3.24% YoY), and the FY2017 full-year result was $76.5 million, down 3.06% from the prior year.
- Non-Current Debt improved to $77.1 million in Q2 2018 per TNDM's latest filing, from $76.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $79.0 million in Q4 2016 and bottomed at $29.3 million in Q4 2015.
- Historically, Non-Current Debt has averaged $50.1 million across 5 years, with a median of $44.3 million in 2016.
- The sharpest annual moves came in 2016 and 2017: Non-Current Debt soared 169.72% in 2016, then slipped 3.06% in 2017.
- Over 5 years, Non-Current Debt stood at $29.4 million in 2014, then dropped by 0.56% to $29.3 million in 2015, then jumped by 169.72% to $79.0 million in 2016, then slipped by 3.06% to $76.5 million in 2017, then increased by 0.73% to $77.1 million in 2018.
- According to Business Quant data, Non-Current Debt over the past three periods registered $77.1 million, $76.4 million, and $76.5 million for Q2 2018, Q1 2018, and Q4 2017 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 77.10 Mn |
| Mar 31, 2018 | 76.41 Mn |
| Dec 31, 2017 | 76.54 Mn |
| Sep 30, 2017 | 75.60 Mn |
| Jun 30, 2017 | 74.68 Mn |
| Mar 31, 2017 | 73.76 Mn |
| Dec 31, 2016 | 78.96 Mn |
| Sep 30, 2016 | 44.68 Mn |
| Jun 30, 2016 | 44.40 Mn |
| Mar 31, 2016 | 44.11 Mn |
| Dec 31, 2015 | 29.28 Mn |
| Sep 30, 2015 | 29.50 Mn |
| Jun 30, 2015 | 29.48 Mn |
| Mar 31, 2015 | 29.46 Mn |
| Dec 31, 2014 | 29.44 Mn |
| Sep 30, 2014 | 29.42 Mn |
| Jun 30, 2014 | 29.39 Mn |
| Mar 31, 2014 | 29.44 Mn |
| Dec 31, 2013 | 29.40 Mn |